NASDAQ$BKYI
Bio-key International Inc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Briefing
BIO-key reported Q1 2025 revenue of $1.6M with a net loss of $736.5K and diluted EPS of $(0.16).
Revenue was $1.6M as EMEA transition from licensed to BIO-key branded products affected year-over-year comparisons. Net loss was $736.5K, or $0.16 per share; cash rose to $3.1M after warrant exercises and gross margin stayed near 83%.
- Q1 revenue $1.6M; gross margin ~83%.
- Cash $3.1M after warrant exercises.
- SG&A down 23% year over year.
- Defense and financial services biometric deployments expanded.
- Management expects EMEA margin recovery in 2025.
Headline financials
Revenue & EPS history
Bio-key · Revenue · Quarterly
$1.61M
Forward guidance
Management discusses operational priorities, capital allocation, and sector risks in the quarterly filing.
Tailwinds
- Execution on core operating metrics cited in MD&A.
- Balance sheet liquidity and covenant headroom.
- Strategic investments supporting long-term growth.
Headwinds
- Macro demand and input-cost volatility.
- Regulatory or competitive pressures in the sector.
- One-time items affecting GAAP comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2024
-3.5%
Avg return
Earnings day
-5.3%
Avg return
5 days after
-8.9%
Avg return
30 days after
25%
16 / 63 earnings
Positive
+15.9%
Q1 2017
Best reaction
-25.9%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.7% | — | — | |
| Q3 2025 | -2.2% | -4.1% | -27.8% | |
| Q1 2025 | -6.0% | -2.5% | -2.5% | |
| Q2 2025 | -1.3% | -3.7% | -4.9% | |
| Q4 2024 | -23.6% | +2.4% | -6.0% | |
| Q3 2024 | -8.7% | -16.5% | -5.8% | |
| Q2 2024 | -12.0% | -12.0% | +8.5% | |
| Q1 2024 | -11.8% | -10.0% | +5.9% | |
| Q4 2025 | -4.1% | -9.5% | -15.0% | |
| Q4 2023 | -4.8% | -13.8% | -19.0% | |
| Q3 2023 | -10.6% | -15.8% | -10.5% | |
| Q2 2023 | -10.0% | -10.0% | -27.1% | |
| Q1 2023 | +5.3% | +21.5% | +13.8% | |
| Q4 2022 | -3.0% | +8.2% | -9.6% | |
| Q3 2022 | -17.4% | -27.1% | -45.1% | |
| Q2 2022 | -17.0% | -22.6% | -27.6% | |
| Q1 2022 | -2.0% | -6.0% | -17.9% | |
| Q4 2021 | -3.2% | -6.0% | -14.0% | |
| Q3 2021 | -8.2% | -10.8% | -27.5% | |
| Q2 2021 | -7.4% | -5.5% | +3.5% | |
| Q1 2021 | +6.1% | +8.4% | +32.3% | |
| Q4 2020 | +2.9% | -0.9% | -2.6% | |
| Q3 2020 | -8.7% | -4.4% | -3.3% | |
| Q2 2020 | +1.1% | -1.4% | -36.5% | |
| Q4 2019 | -24.2% | -20.7% | -9.8% | |
| Q3 2019 | -9.2% | -12.1% | +0.0% | |
| Q2 2019 | +1.8% | -6.8% | -29.5% | |
| Q1 2019 | -6.2% | -16.9% | -13.1% | |
| Q4 2018 | -6.8% | -4.8% | -9.5% | |
| Q3 2018 | +11.1% | +9.3% | +13.9% | |
| Q2 2018 | -2.2% | -2.2% | -10.4% | |
| Q1 2018 | -11.0% | -1.3% | -0.9% | |
| Q4 2017 | -6.5% | +2.0% | +7.6% | |
| Q3 2017 | -10.8% | -6.1% | -29.1% | |
| Q2 2017 | -3.1% | -4.3% | -10.6% | |
| Q1 2017 | +15.9% | +22.0% | +17.5% | |
| Q4 2016 | -7.8% | -5.1% | -14.1% | |
| Q3 2016 | -25.9% | -7.4% | -18.5% | |
| Q2 2016 | +0.0% | -4.2% | +8.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +0.0% | — | — | |
| Q3 2015 | +0.0% | — | — | |
| Q2 2015 | +5.6% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +0.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | +0.0% | — | — | |
| Q1 2014 | -3.7% | — | — | |
| Q4 2013 | +7.7% | — | — | |
| Q3 2013 | -10.5% | — | — | |
| Q2 2013 | +3.0% | — | — | |
| Q1 2013 | +9.1% | — | — | |
| Q4 2012 | +0.0% | — | — | |
| Q3 2012 | +14.3% | — | — | |
| Q1 2012 | +14.3% | — | — | |
| Q4 2011 | -9.1% | — | — | |
| Q3 2010 | -15.4% | — | — | |
| Q3 2011 | -15.4% | — | — | |
| Q2 2010 | +9.1% | — | — | |
| Q2 2011 | +9.1% | — | — | |
| Q1 2011 | -6.7% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro